why don't you guys call investor relations I don't mean Jennifer but talk with Brian Ford.
Instead of speculating, ask them.
when is Immucodin anticipated to be on the market?
Do you plan on partnering?
Has there been any movement on Ecoinche?
What do you percieve as the next catalyst to move the stock price?
Is the company doing any roadshows to analysts?
Are there any potential analysts that could pick up coverage of the company this year?
(and the answer to your question is: I have)